Search Orphan Drug Designations and Approvals
-
Generic Name: | omaveloxolone |
---|---|
Date Designated: | 09/05/2017 |
Orphan Designation: | Treatment of stage IIb through IV malignant melanoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Reata Pharmaceuticals, Inc. 2801 Gateway Dr. Suite 150 Irving, Texas 75063 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-